Insurance for unexpected expenses in case of complications during treatment and 48 months after treatment Coverage up to 200,000 USD


Dr.Cemil Bilir (Clinical oncologist, Gynecologic oncologist, Oncologist/mammologist)– Best Costs, Reviews – Book Your Consultation
Prof. Dr. Cemil Bilir is a distinguished Clinical Oncologist with over 20 years of experience in the field of medical oncology. He currently practices at VM Medical Park Pendik Hospital in Istanbul, Turkey, where he specializes in the treatment of various cancers, including urological, gynecological, lung, and breast cancers. His expertise encompasses immunotherapy, molecular oncology, and clinical research.
Educational Background
- Medical Degree: Istanbul University, Istanbul Faculty of Medicine (1998–2004)
- Internal Medicine Specialization: Düzce University (2005–2009)
- Medical Oncology Specialization: Bülent Ecevit University (2010–2013)
- Associate Professorship: Recep Tayyip Erdoğan University (2015)
- Professor of Medicine: Sakarya University Faculty of Medicine (2020)
- PhD Student in Inorganic Chemistry: Sakarya University (2020–present)
- International Training: Cleveland Clinic, USA (2008); Northeastern University, USA (2016–2017)
Professional Experience
- Current Position: Clinical Oncologist at VM Medical Park Pendik Hospital, Istanbul
- Academic Role: Professor of Medicine at Istinye University, Faculty of Medicine
- Clinical Trials: Principal Investigator and Sub-Investigator in over 20 Phase 2 and 3 clinical trials, focusing on immunotherapies and new targeted therapies
- Previous Positions: Faculty Member at Sakarya University Faculty of Medicine (2015–2021)
Academic Contributions
- Research Interests: Immunotherapy, Molecular Oncology, Gynecological and Urological Cancers
- International Training: Northeastern University, The Center for Pharmaceutical Biotechnology and Nanomedicine, Boston, USA (2016–2017)
- Clinical Trials: Participation in numerous clinical trials, including those sponsored by MSD, AstraZeneca, Roche, Novartis, and Takeda
Areas of Expertise
- Cancer Types Treated:
- Urological Cancers (e.g., prostate, bladder, kidney)
- Gynecological Cancers (e.g., ovarian, endometrial, cervical)
- Lung Cancer
- Breast Cancer
- Treatment Modalities:
- Immunotherapy
- Molecular Targeted Therapy
- Chemotherapy
- Hormone Therapy
- Clinical Trials Participation
Publications and Research
Prof. Dr. Cemil Bilir has contributed to various research initiatives in the field of oncology, focusing on the development and application of novel therapeutic strategies. His work includes participation in international clinical trials and research projects aimed at improving cancer treatment outcomes.
Patient Care Philosophy
Prof. Dr. Cemil Bilir is committed to providing personalized and compassionate care to his patients. He emphasizes clear communication, patient education, and a collaborative approach to treatment planning. His dedication to patient well-being is reflected in the positive feedback from those under his care, highlighting his professionalism and supportive demeanor.
Professional Affiliations
- Turkish Society of Medical Oncology (TTOD)
- American Society of Clinical Oncology (ASCO)
- European Society for Medical Oncology (ESMO)
FAQs
- Is Dr. Cemil Bilir board-certified?
- Yes, Dr. Bilir is board-certified in Medical Oncology and holds professorships at both Recep Tayyip Erdoğan University and Sakarya University.
- What types of cancers does he treat?
- Dr. Bilir specializes in the treatment of urological, gynecological, lung, and breast cancers.
- Does he offer online consultations?
- Yes, online consultations are available for international patients seeking expert oncological advice.
- What is the typical duration of a hospital stay?
- The length of hospital stay varies depending on the type of cancer and treatment plan. Dr. Bilir provides personalized care to determine the appropriate duration for each patient.
- What languages does he speak?
- Dr. Bilir is fluent in Turkish and English, facilitating communication with a diverse patient population.
Patient reviews
Patient reviews









